Viewing Study NCT02310022



Ignite Creation Date: 2024-05-06 @ 3:32 AM
Last Modification Date: 2024-10-26 @ 11:35 AM
Study NCT ID: NCT02310022
Status: COMPLETED
Last Update Posted: 2020-10-12
First Post: 2014-11-14

Brief Title: A PK and PD Study of Two Formulations of Omega-3 One Gram Capsules
Sponsor: Matinas Biopharma Inc
Organization: Matinas Biopharma Inc

Study Overview

Official Title: A Pharmacokinetic and Pharmacodynamic Study of Two Formulations of Omega-3 One Gram Capsules After Single and Multi-Dose Administrations Under Fed Conditions
Status: COMPLETED
Status Verified Date: 2020-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PKPD
Brief Summary: Comparative bioavailability and pharmacodynamics effects of MAT9001 versus an active omega-3 medication comparator
Detailed Description: The primary objective is to determine the comparative bioavailability and pharmacodynamics effects of single and multiple doses of MAT9001 versus an active omega-3 medication comparator

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None